CLASS II Device recall · Reported 20 May 2020 · FDA Enforcement Report

BD Alaris PCEA Administration Set, Microbore Tubing recalled

BD Switzerland Sarl is recalling BD Alaris PCEA Administration Set, Microbore Tubing with Yellow Identification Stripe ASV, distributed nationwide in the US. The recall was initiated on 9 Apr 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Numbers: 19016079 19036183 19045426 19045426 19115483 19115483
Quantity recalled110,350

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1969-2020
FDA event ID
85525
Recalling firm
BD Switzerland Sarl, Eysins, N/A
Classification
Class II
Status
Terminated
Recall initiated
9 Apr 2020
FDA classified
13 May 2020
Reported
20 May 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects
Device type
Infusion Pumps

Timeline

9 Apr 2020Recall initiated by company
13 May 2020Classified by FDA+34 days
20 May 2020Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The products have the potential to leak between the connection of the male luer and the yellow striped tubing. This leak may be observed while priming or during use. The most likely health consequence associated with a leak in an administration set would be inadequate pain control for the patient due to an under-infusion of medication.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

BD Alaris PCEA Administration Set, Microbore Tubing with Yellow Identification Stripe ASV, Catalog Number 30893-04 (OUS Only) - Product Usage: Microbore Tubing with Yellow Identification Stripe Anti-siphon Valve Use Aseptic Technique Set cannot be used for gravity infusion. 1. Connect PCA syringe to female luer on administration set. 2. Push on syringe plunger to prime set. 3. Refer to PCA module Directions for Use for complete loading and operating instructions. Notes: The set should be changed according to facility protocol or in accordance with currently recognized guidelines for IV therapy. Antisiphon sets cannot be primed by gravity.

Where it was distributed

Worldwide distribution - US Nationwide Distribution and the countries of Canada, Belgium.

Nationwide

Questions about this recall

Why was it recalled?

The products have the potential to leak between the connection of the male luer and the yellow striped tubing. This leak may be observed while priming or during use. The most likely health consequence associated with a leak in an administration set would be inadequate pain control for the patient due to an under-infusion of medication.

Which lots are affected?

Lot Numbers: 19016079 19036183 19045426 19045426 19115483 19115483

Where was it sold?

Worldwide distribution - US Nationwide Distribution and the countries of Canada, Belgium.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 85525

This product is part of a recall event; the main page for the event is BD Alaris PCEA Administration Set, Microbore Tubing recalled.

More recalls from BD Switzerland Sarl

All 15

Other Infusion Pumps recalls

All 549